TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 311 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $984,000 | +5.6% | 60,046 | +8.5% | 0.13% | +0.8% |
| Q2 2021 | $932,000 | +76.5% | 55,355 | +75.9% | 0.12% | +5.9% |
| Q1 2021 | $528,000 | +85.3% | 31,474 | +101.3% | 0.12% | +49.4% |
| Q4 2020 | $285,000 | +714.3% | 15,636 | +648.9% | 0.08% | +259.1% |
| Q2 2019 | $35,000 | -22.2% | 2,088 | -9.8% | 0.02% | -26.7% |
| Q1 2019 | $45,000 | +4400.0% | 2,316 | +2759.3% | 0.03% | +2900.0% |
| Q4 2018 | $1,000 | – | 81 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |